Free Trial
→ Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (From Colonial Metals) (Ad) Free NVO Stock Alerts

Novo Nordisk A/S (NVO) Short Interest Ratio & Short Volume

Novo Nordisk A/S logo
$88.06 +4.33 (+5.16%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$88.10 +0.04 (+0.05%)
As of 02/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Novo Nordisk A/S Short Interest Data

Novo Nordisk A/S (NVO) has a short interest of 13.57 million shares. This marks a 64.09% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 9.26 million shares to cover all short positions.

Current Short Interest
13,570,000 shares
Previous Short Interest
8,270,000 shares
Change Vs. Previous Month
+64.09%
Dollar Volume Sold Short
$1.14 billion
Short Interest Ratio
1.7 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
4,487,532,000 shares
Percentage of Shares Shorted
0.30%
Today's Trading Volume
15,117,993 shares
Average Trading Volume
9,263,626 shares
Today's Volume Vs. Average
163%
Short Selling Novo Nordisk A/S?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Novo Nordisk A/S and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

NVO Short Interest Over Time

NVO Days to Cover Over Time

NVO Percentage of Float Shorted Over Time

Novo Nordisk A/S Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202513,570,000 shares $1.14 billion +64.1%N/A1.7 $84.36
1/15/20258,270,000 shares $686.33 million -0.4%N/A1.1 $82.99
12/31/20248,300,000 shares $713.97 million +76.6%N/A1.3 $86.02
12/15/20244,700,000 shares $502.67 million -17.3%N/A0.8 $106.95
11/30/20245,680,000 shares $606.62 million +15.2%N/A1.1 $106.80
11/15/20244,930,000 shares $501.58 million -18.5%N/A1 $101.74
10/31/20246,050,000 shares $677.36 million -4.9%N/A1.4 $111.96
10/15/20246,360,000 shares $749.40 million -9.5%N/A1.6 $117.83
9/30/20247,030,000 shares $836.92 million +21.2%N/A1.7 $119.05
9/15/20245,800,000 shares $794.60 million +13.1%N/A1.5 $137.00
8/31/20245,130,000 shares $713.89 million -2.7%N/A1.3 $139.16
8/15/20245,270,000 shares $724.99 million +30.1%N/A1.3 $137.57
7/31/20244,050,000 shares $537.15 million +28.6%N/A1 $132.63
7/15/20243,150,000 shares $445.38 million -30.3%N/A0.8 $141.39
6/30/20244,520,000 shares $645.18 million +3.7%N/A1.2 $142.74
6/15/20244,360,000 shares $621.30 million -2.7%N/A1.2 $142.50
5/31/20244,480,000 shares $606.14 million +20.8%N/A1.1 $135.30
5/15/20243,710,000 shares $499.51 million +1.9%N/A0.8 $134.64
4/30/20243,640,000 shares $466.94 million +12.4%N/A0.8 $128.28
4/15/20243,240,000 shares $401.27 million +14.5%N/A0.6 $123.85
3/31/20242,830,000 shares $363.37 million -31.1%N/A0.6 $128.40
3/15/20244,110,000 shares $543.96 million -15.8%N/A0.8 $132.35
2/29/20244,880,000 shares $584.33 million +4.5%N/A1 $119.74
2/15/20244,670,000 shares $568.43 million -37.9%N/A1 $121.72
1/31/20247,520,000 shares $862.47 million +37.7%N/A1.7 $114.69
1/15/20245,460,000 shares $585.09 million -5.0%N/A1.3 $107.16
12/31/20235,750,000 shares $594.84 million -11.1%N/A1.3 $103.45
12/15/20236,470,000 shares $628.04 million +15.5%N/A1.4 $97.07
11/30/20235,600,000 shares $570.33 million -6.2%N/A1.2 $101.85
11/15/20235,970,000 shares $575.63 million +34.8%N/A1.3 $96.42
10/31/20234,430,000 shares $427.81 million -26.3%N/A1 $96.57
10/15/20236,010,000 shares $613.86 million +1.7%N/A1.3 $102.14
9/30/20235,910,000 shares $537.46 million +5.4%N/A1.5 $90.94
9/15/20235,610,000 shares $267.03 million +187.7%0.3%1.6 $47.60
8/31/20231,950,000 shares $362.15 million -4.9%0.1%1.2 $185.72
8/15/20232,050,000 shares $379.50 million +106.0%0.1%1.4 $185.12
7/31/2023995,300 shares $160.34 million -21.0%0.1%0.7 $161.10
7/15/20231,260,000 shares $201.78 million -44.3%0.1%1 $160.14
6/30/20232,260,000 shares $365.74 million +9.2%0.1%1.6 $161.83
6/15/20232,070,000 shares $336.44 million +16.3%0.1%1.5 $162.53
Here’s how you could profit from Elon’s NVIDIA partnership (Ad)

"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world.

Get all the details here >>>
5/31/20231,780,000 shares $285.69 million +14.1%0.1%1.3 $160.50
5/15/20231,560,000 shares $264.31 million +6.1%0.1%1.1 $169.43
4/30/20231,470,000 shares $245.62 million -14.5%0.1%1.1 $167.09
4/15/20231,720,000 shares $289.99 million -26.2%0.1%1.2 $168.60
3/31/20232,330,000 shares $370.80 million +66.4%0.1%1.7 $159.14
3/15/20231,400,000 shares $197.37 million +28.4%0.1%1 $140.98
2/28/20231,090,000 shares $153.68 million -3.5%0.1%0.8 $140.99
2/15/20231,130,000 shares $159.28 million -33.9%0.1%0.8 $140.96
1/31/20231,710,000 shares $237.31 million +3.6%0.1%1.2 $138.78
1/15/20231,650,000 shares $224.93 million -10.3%0.1%1.2 $136.32
12/30/20221,840,000 shares $249.03 million +34.3%0.1%1.4 $135.34
12/15/20221,370,000 shares $183.14 million -34.1%0.1%1 $133.68
11/30/20222,080,000 shares $259.17 million -20.6%0.1%1.6 $124.60
11/15/20222,620,000 shares $297.74 million -1.1%0.2%1.8 $113.64
10/31/20222,650,000 shares $288.43 million -17.7%0.2%1.7 $108.84
10/15/20223,220,000 shares $334.24 million +0.9%0.2%2 $103.80
9/30/20223,190,000 shares $317.82 million +2.2%0.2%1.9 $99.63
9/15/20223,120,000 shares $322.02 million -9.0%0.2%1.9 $103.21
8/31/20223,430,000 shares $363.92 million +48.5%0.2%2.1 $106.10
8/15/20222,310,000 shares $245.71 million +76.3%0.1%1.5 $106.37
7/31/20221,310,000 shares $152.04 million +26.0%0.1%0.9 $116.06
7/15/20221,040,000 shares $118.80 million -46.4%N/A0.7 $114.23
6/30/20221,940,000 shares $216.17 million -22.7%N/A1.3 $111.43
6/15/20222,510,000 shares $266.89 million +46.8%N/A1.7 $106.33
5/31/20221,710,000 shares $188.78 million -29.1%0.1%1.2 $110.40
5/15/20222,410,000 shares $255.56 million +39.3%0.1%1.6 $106.04
4/30/20221,730,000 shares $197.22 million -47.1%0.1%1.2 $114.00
4/15/20223,270,000 shares $386.51 million +58.0%0.2%2.3 $118.20
3/31/20222,070,000 shares $229.87 million -21.3%0.1%1.4 $111.05
3/15/20222,630,000 shares $269.44 million +10.0%0.2%1.7 $102.45
2/28/20222,390,000 shares $246.05 million -4.8%0.1%1.5 $102.95
2/15/20222,510,000 shares $254.41 million -24.6%0.1%1.7 $101.36
1/31/20223,330,000 shares $332.57 million +0.3%0.2%2.4 $99.87
1/15/20223,320,000 shares $319.78 million +18.2%0.2%2.6 $96.32
12/31/20212,810,000 shares $314.72 million +42.6%0.2%2.5 $112.00
12/15/20211,970,000 shares $229.43 million +3.1%0.1%1.9 $116.46
11/30/20211,910,000 shares $204.05 million -26.0%0.1%2.2 $106.83
11/15/20212,580,000 shares $292.80 million +22.3%0.2%2.8 $113.49
10/29/20212,110,000 shares $232.37 million -17.3%0.1%2.2 $110.13
10/15/20212,550,000 shares $260.97 million +8.1%0.2%2.5 $102.34
9/30/20212,360,000 shares $226.58 million -10.3%0.1%2.3 $96.01
9/15/20212,630,000 shares $266.34 million -24.0%0.2%2.6 $101.27
8/31/20213,460,000 shares $345.90 million +19.7%0.2%3.5 $99.97
8/13/20212,890,000 shares $296.98 million -30.5%0.2%3 $102.76
7/30/20214,160,000 shares $385.22 million -11.1%0.2%4.2 $92.60
7/15/20214,680,000 shares $410.01 million -5.1%0.3%5.2 $87.61
6/30/20214,930,000 shares $412.99 million -1.6%0.3%5.6 $83.77
6/15/20215,010,000 shares $423.70 million +7.1%0.3%5.6 $84.57
5/28/20214,680,000 shares $369.25 million +15.0%0.3%5.3 $78.90
5/14/20214,070,000 shares $321.08 million -15.2%0.2%4.6 $78.89
Here’s how you could profit from Elon’s NVIDIA partnership (Ad)

"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world.

Get all the details here >>>
4/30/20214,800,000 shares $356.35 million +11.9%0.3%5 $74.24
4/15/20214,290,000 shares $302.66 million +1.4%0.2%4.4 $70.55
3/31/20214,230,000 shares $287.30 million -0.9%0.2%4.3 $67.92
3/15/20214,270,000 shares $303.21 million -6.2%0.2%4 $71.01
2/26/20214,550,000 shares $329.15 million +4.6%0.3%4.2 $72.34
2/12/20214,350,000 shares $321.60 million -12.7%0.2%4 $73.93
1/29/20214,980,000 shares $351.59 million +1.4%0.3%4.6 $70.60
1/15/20214,910,000 shares $348.76 million +21.2%0.3%4.3 $71.03
12/31/20204,050,000 shares $284.31 million -1.0%0.2%3.6 $70.20
12/15/20204,090,000 shares $281.06 million -17.9%0.2%3.6 $68.72
11/30/20204,980,000 shares $336.35 million -12.2%0.3%4.5 $67.54
11/15/20205,670,000 shares $386.01 million +13.2%0.3%5.3 $68.08
10/30/20205,010,000 shares $332.31 million +21.6%0.3%4.8 $66.33
10/15/20204,120,000 shares $295.53 million -1.2%0.2%4.4 $71.73
9/30/20204,170,000 shares $289.52 million -10.9%0.2%4.4 $69.43
9/15/20204,680,000 shares $317.87 million +19.1%0.3%4.9 $67.92
8/31/20203,930,000 shares $259.54 million +4.2%0.2%3.6 $66.04
8/14/20203,770,000 shares $247.95 million +35.1%0.2%3.3 $65.77
7/31/20202,790,000 shares $182.27 million -1.4%0.2%2.2 $65.33
7/15/20202,830,000 shares $185.34 million -17.5%0.2%2.2 $65.49
6/30/20203,430,000 shares $224.60 million No Change0.2%2.1 $65.48
6/15/20203,430,000 shares $221.61 million +25.2%0.2%1.8 $64.61
5/29/20202,740,000 shares $180.68 million +21.8%0.2%1.3 $65.94
5/15/20202,250,000 shares $144.65 million No Change0.1%1 $64.29
4/30/20202,250,000 shares $142.49 million -13.1%0.1%1 $63.33
4/15/20202,590,000 shares $155.01 million -22.2%0.1%1.1 $59.85
3/31/20203,330,000 shares $216.15 million -34.8%0.2%1.6 $64.91
3/13/20205,108,900 shares $306.53 million +9.9%0.4%3.4 $60.00
2/28/20204,650,000 shares $234.41 million -10.8%0.3%3.1 $50.41

NVO Short Interest - Frequently Asked Questions

What is Novo Nordisk A/S's current short interest?

Short interest is the volume of Novo Nordisk A/S shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 13,570,000 shares of NVO short. Learn More on Novo Nordisk A/S's current short interest.

What is a good short interest ratio for Novo Nordisk A/S?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVO shares currently have a short interest ratio of 2.0. Learn More on Novo Nordisk A/S's short interest ratio.

Which institutional investors are shorting Novo Nordisk A/S?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Novo Nordisk A/S: Toronto Dominion Bank, GTS Securities LLC, Arrowpoint Investment Partners Singapore Pte. Ltd., Wolverine Trading LLC, Squarepoint Ops LLC, Tidal Investments LLC, Shay Capital LLC, Sig Brokerage LP, Point72 Asset Management L.P., Nomura Holdings Inc., OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC , Millennium Management LLC, LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Caption Management LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., 683 Capital Management LLC, Jane Street Group LLC, Optiver Holding B.V., Tudor Investment Corp ET AL, Artia Global Partners LP, CMT Capital Markets Trading GmbH, Parallax Volatility Advisers L.P., Susquehanna International Group LLP, Hsbc Holdings PLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Kopernik Global Investors LLC, Capital Fund Management S.A., DRW Securities LLC, ADAR1 Capital Management LLC, National Bank of Canada FI, JPMorgan Chase & Co., Simplex Trading LLC, Twin Tree Management LP, Valeo Financial Advisors LLC, Genus Capital Management Inc., IMC Chicago LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Novo Nordisk A/S's short interest increasing or decreasing?

Novo Nordisk A/S saw a increase in short interest in January. As of January 31st, there was short interest totaling 13,570,000 shares, an increase of 64.1% from the previous total of 8,270,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Novo Nordisk A/S's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Novo Nordisk A/S: AstraZeneca PLC (0.55%), Novartis AG (0.21%), Sanofi (0.20%), GSK plc (0.85%), Takeda Pharmaceutical Company Limited (0.12%), argenx SE (3.32%), BioNTech SE (1.14%), Teva Pharmaceutical Industries Limited (1.97%), Summit Therapeutics Inc. (2.83%), Genmab A/S (0.26%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short Novo Nordisk A/S stock?

Short selling NVO is an investing strategy that aims to generate trading profit from Novo Nordisk A/S as its price is falling. NVO shares are trading up $4.33 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Novo Nordisk A/S?

A short squeeze for Novo Nordisk A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVO, which in turn drives the price of the stock up even further.

How often is Novo Nordisk A/S's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVO, twice per month. The most recent reporting period available is January, 31 2025.



Related Companies
Short Interest Tools

This page (NYSE:NVO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
What is this southern state hiding?
The financial press had a field day this week after President Donald Trump and Department of Government Effici...
Stansberry Research | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
How to trade Executive Order 14154
Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...
Porter & Company | Sponsored
Major AI announcement for 2025
BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI Stocks
Brownstone Research | Sponsored